Adaptive Biotechnologies Corp Share Price Today: Live Updates & Key Insights

Adaptive Biotechnologies Corp share price today is $13.75, up 0.59%. The stock opened at $13.29 against the previous close of $13.5, with an intraday high of $13.6 and low of $13.2.

Adaptive Biotechnologies Corp Share Price Chart

Adaptive Biotechnologies Corp

us-stock
To Invest in {{usstockname}}
us-stock

Adaptive Biotechnologies Corp Share Price Performance

$13.75 0.0059(0.59%) ADPT at 23 Mar 2026 11:53 AM Biotechnology
Lowest Today 13.2
Highest Today 13.6
Today’s Open 13.29
Prev. Close 13.5
52 Week High 20.76
52 Week Low 6.68
Day’s Range: Low 13.2 High 13.6
52-Week Range: Low 6.68 High 20.76
1 day return -
1 Week return +2.1
1 month return -11.69
3 month return -21.94
6 month return -2.61
1 year return +57.1
3 year return +71.59
5 year return -68.45
10 year return -

Adaptive Biotechnologies Corp Institutional Holdings

Viking Global Investors LP 19.48

BlackRock Inc 8.68

Vanguard Group Inc 7.33

Ameriprise Financial Inc 3.88

Vanguard Total Stock Mkt Idx Inv 2.97

Westfield Capital Management Company, L.P. 2.64

Sumitomo Mitsui Trust Group Inc 2.37

iShares Russell 2000 ETF 2.37

Geode Capital Management, LLC 2.28

Lord, Abbett & Co LLC 2.00

State Street Corp 2.00

Driehaus Capital Management LLC 1.79

Jennison Associates LLC 1.74

Arrowstreet Capital Limited Partnership 1.57

Fred Alger Management, LLC 1.46

Wellington Management Company LLP 1.41

ARK Investment Management LLC 1.39

ARK Genomic Revolution ETF 1.38

Macquarie Group Ltd 1.37

ARK Genomic Revolution 1.34

Amova Asset Management Americas, Inc 1.27

D. E. Shaw & Co LP 1.24

The Goldman Sachs Group Inc 1.22

Aristotle Atlantic Partners, LLC 1.20

Lord Abbett Developing Growth A 1.10

US Small-Cap Growth II Equity Comp 1.07

Vanguard Small Cap Index 1.07

Xtrackers MSCI World Swap ETF 1C 1.03

Alger Small Cap Focus Composite 1.03

Alger Small Cap Focus I 1.03

Fidelity Small Cap Index 0.95

Amova ARK Pstv Chg Innovt P JPY Acc 0.92

Vanguard Institutional Extnd Mkt Idx Tr 0.82

iShares Russell 2000 Growth ETF 0.81

T. Rowe Price Integrated US SmCapGrEq 0.72

T. Rowe Price Integrated US Sm Gr Eq 0.72

iShares Biotechnology ETF 0.71

BNP Paribas US Small Cap ClassicC 0.71

Jennison SMid Cap Core Equity 0.67

PGIM Jennison Small Company A 0.67

Adaptive Biotechnologies Corp Market Status

Strong Buy: 3

Buy: 4

Hold: 1

Sell: 0

Strong Sell: 0

Adaptive Biotechnologies Corp Fundamentals

Market Cap 2091.07 M

PB Ratio 9.5573

PE Ratio 0.0

Enterprise Value 1943.24 M

Total Assets 512.74 M

Volume 2360426

Adaptive Biotechnologies Corp Company Financials

Annual Revenue FY25:276976000 277.0M, FY23:179690000 179.7M, FY22:185308000 185.3M, FY21:154344000 154.3M, FY20:98382000 98.4M

Annual Profit FY25:205617000 205.6M, FY23:107164000 107.2M, FY22:127399000 127.4M, FY21:105043000 105.0M, FY20:75852000 75.9M

Annual Net worth FY25:-59499000 -59.5M, FY23:-195937000 -195.9M, FY22:-142464000 -142.5M, FY21:-205611000 -205.6M, FY20:-139637000 -139.6M

Quarterly Revenue Q4/2025:71681000 71.7M, Q3/2025:93973000 94.0M, Q2/2025:58879000 58.9M, Q1/2025:52443000 52.4M, Q3/2024:46435000 46.4M

Quarterly Profit Q4/2025:53457000 53.5M, Q3/2025:75816000 75.8M, Q2/2025:40880000 40.9M, Q1/2025:35464000 35.5M, Q3/2024:29768000 29.8M

Quarterly Net worth Q4/2025:-13579000 -13.6M, Q3/2025:9546000 9.5M, Q2/2025:-25614000 -25.6M, Q1/2025:-29852000 -29.9M, Q3/2024:-32071000 -32.1M

About Adaptive Biotechnologies Corp & investment objective

Company Information Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Organisation Biotechnology

Employees 624

Industry Biotechnology

CEO Mr. Chad M. Robins M.B.A.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Adaptive Biotechnologies Corp FAQs

What is the share price of Adaptive Biotechnologies Corp today?

The current share price of Adaptive Biotechnologies Corp is $13.75.

Can I buy Adaptive Biotechnologies Corp shares in India?

Yes, Indian investors can buy Adaptive Biotechnologies Corp shares by opening an international trading and demat account with Motilal Oswal.

How to buy Adaptive Biotechnologies Corp shares in India?

You can easily invest in Adaptive Biotechnologies Corp shares from India by:

Can I buy fractional shares of Adaptive Biotechnologies Corp?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Adaptive Biotechnologies Corp?

Adaptive Biotechnologies Corp has a market cap of $2091.07 M.

In which sector does Adaptive Biotechnologies Corp belong?

Adaptive Biotechnologies Corp operates in the Biotechnology sector.

What documents are required to invest in Adaptive Biotechnologies Corp stocks?

To invest, you typically need:

What is the PE and PB ratio of Adaptive Biotechnologies Corp?

The PE ratio of Adaptive Biotechnologies Corp is N/A and the PB ratio is 9.56.